William S Harris1, Juhua Luo2, James V Pottala3, Mark A Espeland4, Karen L Margolis5, Joann E Manson6, Lu Wang6, Theodore M Brasky7, Jennifer G Robinson8. 1. Department of Internal Medicine, Sanford School of Medicine, University of South Dakota, Sioux Falls, SD, USA; OmegaQuant Analytics, LLC, Sioux Falls, SD, USA. Electronic address: bill@omegaquant.com. 2. Department of Epidemiology and Biostatistics, School of Public Health, Indiana University, Bloomington, IN, USA. 3. Department of Internal Medicine, Sanford School of Medicine, University of South Dakota, Sioux Falls, SD, USA. 4. Department of Biostatistical Sciences, Wake Forest School of Medicine, Winston-Salem, NC, USA. 5. HealthPartners Institute, Minneapolis, MN, USA. 6. Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. 7. Comprehensive Cancer Center, Ohio State University, Columbus, OH, USA. 8. Department of Epidemiology, College of Public Health and Department of Internal Medicine, College of Medicine, University of Iowa, Iowa City, IA, USA.
Abstract
BACKGROUND: The prognostic value of circulating polyunsaturated fatty acid (PUFA) levels is unclear. OBJECTIVES: To determine the associations between red blood cell (RBC) PUFA levels and risk for death. METHODS: This prospective cohort study included 6501 women aged 65 to 80 years who participated in the Women's Health Initiative Memory Study (enrolment began 1996). RBC PUFA levels were measured at baseline and expressed as a percent of total RBC PUFAs. PUFAs of primary interest were the n-3 PUFAs eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) and their sum (the Omega-3 Index). PUFAs of secondary interest included the 2 major n-6 PUFAs, linoleic acid and arachidonic acid, and the PUFA factor score (a calculated variable including 6 PUFAs that accounts for their intercorrelations). The primary outcome was total mortality through August 2014. RESULTS: After a median of 14.9 years of follow-up, 1851 women (28.5%) had died. RBC levels of EPA and DHA were higher in the survivors (P < .002 for each). In the fully adjusted models, the hazard ratios (99% confidence intervals) for mortality associated with a 1 standard deviation PUFA increase for total mortality were 0.92 (0.85, 0.98) for the Omega-3 Index, 0.89 (0.82, 0.96) for EPA, 0.93 (0.87, 1.0) for DHA, and 0.76 (0.64, 0.90) for the PUFA factor score. There were no significant associations of alpha-linolenic acid, arachidonic acid or linoleic acid with total mortality. CONCLUSIONS: Higher RBC levels of marine n-3 PUFAs were associated with reduced risk for all-cause mortality. These findings support the beneficial relationship between the Omega-3 Index and health outcomes.
BACKGROUND: The prognostic value of circulating polyunsaturated fatty acid (PUFA) levels is unclear. OBJECTIVES: To determine the associations between red blood cell (RBC) PUFA levels and risk for death. METHODS: This prospective cohort study included 6501 women aged 65 to 80 years who participated in the Women's Health Initiative Memory Study (enrolment began 1996). RBC PUFA levels were measured at baseline and expressed as a percent of total RBC PUFAs. PUFAs of primary interest were the n-3 PUFAseicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) and their sum (the Omega-3 Index). PUFAs of secondary interest included the 2 major n-6 PUFAs, linoleic acid and arachidonic acid, and the PUFA factor score (a calculated variable including 6 PUFAs that accounts for their intercorrelations). The primary outcome was total mortality through August 2014. RESULTS: After a median of 14.9 years of follow-up, 1851 women (28.5%) had died. RBC levels of EPA and DHA were higher in the survivors (P < .002 for each). In the fully adjusted models, the hazard ratios (99% confidence intervals) for mortality associated with a 1 standard deviation PUFA increase for total mortality were 0.92 (0.85, 0.98) for the Omega-3 Index, 0.89 (0.82, 0.96) for EPA, 0.93 (0.87, 1.0) for DHA, and 0.76 (0.64, 0.90) for the PUFA factor score. There were no significant associations of alpha-linolenic acid, arachidonic acid or linoleic acid with total mortality. CONCLUSIONS: Higher RBC levels of marine n-3 PUFAs were associated with reduced risk for all-cause mortality. These findings support the beneficial relationship between the Omega-3 Index and health outcomes.
Authors: J David Curb; Anne McTiernan; Susan R Heckbert; Charles Kooperberg; Janet Stanford; Michael Nevitt; Karen C Johnson; Lori Proulx-Burns; Lisa Pastore; Michael Criqui; Sandra Daugherty Journal: Ann Epidemiol Date: 2003-10 Impact factor: 3.797
Authors: Jackie Bosch; Hertzel C Gerstein; Gilles R Dagenais; Rafael Díaz; Leanne Dyal; Hyejung Jung; Aldo P Maggiono; Jeffrey Probstfield; Ambady Ramachandran; Matthew C Riddle; Lars E Rydén; Salim Yusuf Journal: N Engl J Med Date: 2012-06-11 Impact factor: 91.245
Authors: Matti Marklund; Karin Leander; Max Vikström; Federica Laguzzi; Bruna Gigante; Per Sjögren; Tommy Cederholm; Ulf de Faire; Mai-Lis Hellénius; Ulf Risérus Journal: Circulation Date: 2015-06-17 Impact factor: 29.690
Authors: Griffith A Bell; Elizabeth D Kantor; Johanna W Lampe; Alan R Kristal; Susan R Heckbert; Emily White Journal: Am J Epidemiol Date: 2014-02-03 Impact factor: 4.897
Authors: Eric A Gurzell; Jason A Wiesinger; Christina Morkam; Sophia Hemmrich; William S Harris; Jenifer I Fenton Journal: Prostaglandins Leukot Essent Fatty Acids Date: 2014-04-24 Impact factor: 4.006
Authors: Liana C Del Gobbo; Fumiaki Imamura; Stella Aslibekyan; Matti Marklund; Jyrki K Virtanen; Maria Wennberg; Mohammad Y Yakoob; Stephanie E Chiuve; Luicito Dela Cruz; Alexis C Frazier-Wood; Amanda M Fretts; Eliseo Guallar; Chisa Matsumoto; Kiesha Prem; Tosh Tanaka; Jason H Y Wu; Xia Zhou; Catherine Helmer; Erik Ingelsson; Jian-Min Yuan; Pascale Barberger-Gateau; Hannia Campos; Paulo H M Chaves; Luc Djoussé; Graham G Giles; Jose Gómez-Aracena; Allison M Hodge; Frank B Hu; Jan-Håkan Jansson; Ingegerd Johansson; Kay-Tee Khaw; Woon-Puay Koh; Rozenn N Lemaitre; Lars Lind; Robert N Luben; Eric B Rimm; Ulf Risérus; Cecilia Samieri; Paul W Franks; David S Siscovick; Meir Stampfer; Lyn M Steffen; Brian T Steffen; Michael Y Tsai; Rob M van Dam; Sari Voutilainen; Walter C Willett; Mark Woodward; Dariush Mozaffarian Journal: JAMA Intern Med Date: 2016-08-01 Impact factor: 21.873
Authors: Claudia L Satizabal; Cécilia Samieri; Kendra L Davis-Plourde; Barbara Voetsch; Hugo J Aparicio; Matthew P Pase; José Rafael Romero; Catherine Helmer; Ramachandran S Vasan; Carlos S Kase; Stéphanie Debette; Alexa S Beiser; Sudha Seshadri Journal: Stroke Date: 2018-12 Impact factor: 7.914
Authors: Andrea Elmore; William S Harris; Lina Mu; William E Brady; Kathleen M Hovey; Julie A Mares; Mark A Espeland; Mary N Haan; Amy E Millen Journal: Eur J Nutr Date: 2022-01-06 Impact factor: 5.614
Authors: William S Harris; Nathan L Tintle; JoAnn E Manson; Adam H Metherel; Jennifer G Robinson Journal: Am J Clin Nutr Date: 2021-06-01 Impact factor: 7.045
Authors: Michael I McBurney; Jeffrey B Blumberg; Rebecca B Costello; Manfred Eggersdorfer; John W Erdman; William S Harris; Elizabeth J Johnson; Susan Hazels Mitmesser; Robert C Post; Deshanie Rai; Leon J Schurgers Journal: Nutrients Date: 2021-05-28 Impact factor: 5.717